[1] Witlox MA, Lamfers ML, Wuisman PL, et al. Evolving genetherapy approaches for osteosarcoma using viral vectors: review[J].Bone,2007,40(4):797-812.
[2] 裴锋，张克亮.核因子-kB和环氧合酶-2在胃癌组织中的表达与肿瘤微血管形成的关系[J].华中科技大学学报:医学版，2007,36 (3):355- 358.
[3] 刘江月，王冉冉，王海英，等.胃癌组织中NF-kB和COX-2的表达及临床意义[J].国际病理科学与临床杂志，2008,28(2):108-112.
[4] 钟华，廖爱军，刘迪群，等.MMP-2、MMP-9与胃癌侵袭、转移的关系[J].实用临床医学，2012,13 (2):3 -4.
[5] 王洪兴，秦川，张贵虎，等.胃癌组织中KISS}和MMP-9的表达及其意义[J].山东医药，2010,50 (24):9-11.
[6] Gaspanrinni G, Weidner N, Bevilacqua P, et al. Tumor microvesseldensity, p53 expression, tumor size, and peritumoral lymphatic vesselinvasion are relevant prognostic marker in nodenegative breastcarcinoma[J].Clin Onco1,1994,12 (3):454-466.
[7] Sonic D, Richardson,JA, Yu K, et al.Twist regulates cytokine geneexpression through a negative feedback loop that rep resses NF-kB activity[J].Cell, 2003，112 (2):169-180.
[8] Hoekstra R, Eskens F, Verweij J. Matrix metalloproteinaseinhibitors: current developments and future perspectives.Oncologist,2001,6(5):415-427.
[9] Sinqer CA, BakerKJ，McCaffrey A,et al. p38 MAPK and NF-kBmediate COX-2 expression in human airway myocytes[J].Am JPhysiol Lung Cell Mol Physio1,2003,285 (5):1087-1098.
[10] Gately S.The contributions of cyclooxygenase-2 to tumor angiogenesis[J].Cancer Metastasis Rev, 2000,19 ( 1/2):19-27.